193
Views
5
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Protective effects of taurine against hepatotoxicity induced by pharmaceuticals and environmental chemicals

, , & ORCID Icon
Pages 56-84 | Received 22 Jan 2021, Accepted 11 Feb 2021, Published online: 11 Mar 2021

References

  • Abdel-Daim, M. M., A. A. Dessouki, H. G. Abdel-Rahman, R. Eltaysh, and S. Alkahtani. 2019. “Hepatorenal Protective Effects of Taurine and N-Acetylcysteine Against Fipronil-Induced Injuries: The Antioxidant Status and Apoptotic Markers Expression in Rats.” The Science of the Total Environment 650 (Pt 2): 2063–2073. doi:10.1016/J.Scitotenv.2018.09.313.
  • Abdel-Moneim, A. M., M. A. Al-Kahtani, M. A. El-Kersh, and M. A. Al-Omair. 2015. “Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin Against CCl4 Induced Rat Liver Damage.” PloS One 10 (12): e0144509. doi:10.1371/Journal.Pone.0144509.
  • Acharya, M., and C. A. Lau-Cam. 2010. “Comparison of the Protective Actions of N-Acetylcysteine, Hypotaurine of Taurine Against Acetaminophen-Induced Hepatotoxicity in the Rat.” Journal of Biomedical Science 17 (Suppl 1): S35. doi:10.1186/1423-0127-17-S1-S35.
  • Ahsan, M. R., K. M. Islam, I. J. Bulbul, M. A. Musaddik, and E. Haque. 2009. “Hepatoprotective Activity of Methanol Extract of Some Medicinal Plants Against Carbon Tetrachloride-Induced Hepatotoxicity in Rats.” European Journal of Scientific Research 37 (2): 302–310.
  • Alam, S. S., N. A. Hafiz, and A. H. Abd El-Rahim. 2011. “Protective Role of Taurine Against Genotoxic Damage in Mice Treated with Methotrexate and Tamoxfine.” Environ Toxicol Pharmacol 31 (1): 143–152. doi:10.1016/J.Etap.2010.10.001.
  • Alamolhodaei, N. S., K. Shirani, and G. Karimi. 2015. “Arsenic Cardiotoxicity: An Overview.” Environmental Toxicology and Pharmacology 40 (3): 1005–1014. doi:10.1016/j.etap.2015.08.030.
  • Al-Asmari, A. K., A. M. Al-Zahrani, A. Q. Khan, H. M. Al-Shahrani, and M. Ali Al Amri. 2016. “Taurine Ameliorates 5-Flourouracil-Induced Intestinal Mucositis, Hepatorenal and Reproductive Organ Damage in Wistar Rats: A Biochemical and Histological Study.” Human & Experimental Toxicology 35 (1): 10–20. doi:10.1177/0960327115573597.
  • Albano, E., S. W. French, and M. Ingelman-Sundberg. 1999. “Hydroxyethyl Radicals in Ethanol Hepatotoxicity.” Frontiers in Bioscience : A Journal and Virtual Library 4 (4): D533–D540. doi:10.2741/A449.
  • Apaydin, F. G., A. Aslanturk, M. Uzunhisarcikli, H. Bas, S. Kalender, and Y. Kalender. 2019. “Histopathological and Biochemical Studies on the Effect of Curcumin and Taurine Against Bisphenol a Toxicity in Male Rats.” Environmental Science and Pollution Research International 26 (12): 12302–12310. doi:10.1007/S11356-019-04578-4.
  • Balarastaghi, S., Z. Khashaiarmanesh, P. Makhdoumi, S. H. Alavizadeh, Z. Sameie Moghadam, K. Shirani, and G. Karimi. 2018. “Determination of Toxic Element Levels (Lead and Cadmium) in Commonly Used Cosmetic Products in Iran.” Toxin Reviews 37 (2): 117–122. doi:10.1080/15569543.2017.1328603.
  • Balkan, J., Ö. Kanbagli, G. Aykaç-Toker, and M. Uysal. 2002. “Taurine Treatment Reduces Hepatic Lipids and Oxidative Stress in Chronically Ethanol-Treated Rats.” Biological and Pharmaceutical Bulletin 25 (9): 1231–1233. doi: 10.1248/bpb.25.1231.
  • Boşgelmez, İİ., T. Söylemezoğlu, and G. Güvendik. 2008. “The Protective and Antidotal Effects of Taurine on Hexavalent Chromium-Induced Oxidative Stress in Mice Liver Tissue.” Biological Trace Element Research 125 (1): 46–58. doi:10.1007/s12011-008-8154-3.
  • Chaoyue, W., L. Fengna, D. Yehui, G. Qiuping, W. Wenlong, Z. Lingyu, L. Jianzhong, H. Shanping, C. Wen, and Y. Yulong. 2019. “Dietary Taurine Regulates Free Amino Acid Profiles and Taurine Metabolism in Piglets with Diquat-Induced Oxidative Stress.” Journal of Functional Foods 62: 103569. doi:10.1016/j.jff.2019.103569.
  • Cheng, H. S., and M. Rademaker. 2018. “Monitoring Methotrexate-Induced Liver Fibrosis in Patients with Psoriasis: Utility of Transient Elastography.” Psoriasis: Targets and Therapy 8: 21–29. doi:10.2147/PTT.S141629.
  • Costa, M., and C. B. Klein. 2006. “Toxicity and Carcinogenicity of Chromium Compounds in Humans.” Critical Reviews in Toxicology 36 (2): 155–163. doi:10.1080/10408440500534032.
  • Das, J., J. Ghosh, P. Manna, and P. C. Sil. 2010b. “Protective Role of Taurine Against Arsenic-Induced Mitochondria-Dependent Hepatic Apoptosis via the Inhibition of PKCdelta-JNK pathway.” Plos One 5 (9): e12602. doi:10.1371/journal.pone.0012602.
  • Das, J., J. Ghosh, P. Manna, and, and P. C. Sil. 2010a. “Acetaminophen Induced Acute Liver Failure via Oxidative Stress and JNK Activation: Protective Role of Taurine by the Suppression of Cytochrome P450 2E1.” Free Radic Res 44 (3): 340–355. doi:10.3109/10715760903513017.
  • Dinçer, S., S. Özenirler, E. Öz, G. Akyol, and C. Özoğul. 2002. “The Protective Effect of Taurine Pretreatment on Carbon Tetrachloride-Induced Hepatic damage-a light and electron microscopic study.” Amino Acids 22 (4): 417–426. doi:10.1007/S007260200025.
  • Eftekhari, A., E. Ahmadian, Y. Azarmi, A. Parvizpur, J. K. Fard, and M. A. Eghbal. 2018. “The Effects of Cimetidine, N-Acetylcysteine, and Taurine on Thioridazine Metabolic Activation and Induction of Oxidative Stress in Isolated Rat Hepatocytes.” Pharmaceutical Chemistry Journal 51 (11): 965–969. doi:10.1007/s11094-018-1724-6.
  • Eghbal, M. A., S. Taziki, and M. R. Sattari. 2013. “Protective Role of Melatonin and Taurine Against Carbamazepine-Induced Toxicity in Freshly Isolated Rat Hepatocytes.” International Journal of Morphology 31 (3): 1081–1089. doi:10.4067/S0717-95022013000300049.
  • Eghbal, M. A., S. Taziki, and M. R. Sattari. 2014. “Mechanisms of Phenytoin-Induced Toxicity in Freshly Isolated Rat Hepatocytes and the Protective Effects of Taurine and/or Melatonin .” Journal of Biochemical and Molecular Toxicology 28 (3): 111–118. doi:10.1002/jbt.21542.
  • Erman, F., J. Balkan, U. Cevikbaş, N. Kocak-Toker, and M. Uysal. 2004. “Betaine or Taurine Administration Prevents Fibrosis and Lipid Peroxidation Induced by Rat Liver by Ethanol plus Carbon Tetrachloride Intoxication.” Amino Acids 27 (2): 199–205. doi:10.1007/s00726-004-0105-5.
  • Fard, J. K., H. Hamzeiy, M. Sattari, and M. A. Eghbal. 2016. “Protective Roles of N-Acetyl Cysteine and/or Taurine Against Sumatriptan-Induced Hepatotoxicity.” Advanced Pharmaceutical Bulletin 6 (4): 627–637. doi:10.15171/apb.2016.077.
  • Fukuno, S., K. Nagai, S. Yoshida, H. Suzuki, and H. Konishi. 2016. “Taurine as a Protective Agent for 5-Fluorouracil-Induced Hepatic Damage Related to Oxidative Stress.” Die Pharmazie 71 (9): 530–532. doi:10.1691/ph.2016.6611.
  • Gabr, S. A., N. S. Gabr, and W. M. Elsaed. 2019. “Protective Activity of Taurine and Molecular Fibrogenesis in Iron Overloaded Hepatic Tissues.” International Journal of Pharmacology 15 (3): 418–427. doi:10.3923/ijp.2019.418.427.
  • Gallelli, L., O. Staltari, C. Palleria, G. De Sarro, and M. Ferraro. 2009. “Hepatotoxicity Induced by Methimazole in a Previously Healthy Patient.” Current Drug Safety 4 (3): 204–206. doi:10.2174/157488609789006912.
  • Gao, N., X. Yao, L. Jiang, L. Yang, T. Qiu, Z. Wang, P. Pei, G. Yang, X. Liu, and X. Sun. 2019. “Taurine Improves Low-Level Inorganic Arsenic-Induced Insulin Resistance by Activating PPARγ-mTORC2 Signalling and Inhibiting Hepatic Autophagy.” Journal of Cellular Physiology 234 (4): 5143–5152. doi:10.1002/jcp.27318.
  • Goc, Z., E. Kapusta, G. Formicki, M. Martiniaková, and R. Omelka. 2019. “Effect of Taurine on Ethanol-Induced Oxidative Stress in Mouse Liver and Kidney.” The Chinese Journal of Physiology 62 (4): 148–156. doi:10.4103/Cjp.Cjp_28_19.
  • Guldberg Klenø, T., L. Rønnedal Leonardsen, H. Ørsted Kjeldal, S. Møller Laursen, O. N. Jensen, and D. Baunsgaard. 2004. “Mechanisms of Hydrazine Toxicity in Rat Liver Investigated by Proteomics and Multivariate Data Analysis.” Proteomics 4 (3): 868–880. doi:10.1002/Pmic.200300663.
  • Gupta, R. C., M. D’Archivio, and R. Masella. 2009. “Taurine as Drug and Functional Food Component.” In Glutathione and Sulfur Amino Acids in Human Health and Disease, edited by R. Masella and G. Mazza, 519–541. Hoboken, NJ: Wiley.
  • Hagar, H. H. 2004. “The Protective Effect of Taurine Against Cyclosporine A-Induced Oxidative Stress and Hepatotoxicity in Rats.” Toxicology Letters 151 (2): 335–343. doi:10.1016/j.toxlet.2004.03.002.
  • Heidari, R., H. Babaei, and M. A. Eghbal. 2012. “Ameliorative Effects of Taurine Against Methimazole-Induced Cytotoxicity in Isolated Rat Hepatocytes.” Scientia Pharmaceutica 80 (4): 987–1000. doi:10.3797/scipharm.1205-16.
  • Heidari, R., H. Babaei, and M. A. Eghbal. 2013. “Cytoprotective Effects of Taurine Against Toxicity Induced by Isoniazid and Hydrazine in Isolated Rat Hepatocytes.” Archives of Industrial Hygiene and Toxicology 64 (2): 201–210. doi:10.2478/10004-1254-64-2013-2297.
  • Hölttä, E., R. Sinervirta, and J. Jänne. 1973. “Synthesis and Accumulation of Polyamines in Rat Liver Regenerating after Treatment with Carbon Tetrachloride.” Biochemical and Biophysical Research Communications 54 (1): 350–357. doi:10.1016/0006-291X(73)90929-7.
  • Huxtable, R. J., and L. A. Sebring. 1986. “Towards a Unifying Theory for the Actions of Taurine.” Trends in Pharmacological Sciences 7: 481–485. 7: doi:10.1016/0165-6147(86)90433-5.
  • Hwang, D. F., and L. C. Wang. 2001. “Effect of Taurine on Toxicity of Cadmium in Rats.” Toxicology 167 (3): 173–180. doi:10.1016/S0300-483X(01)00472-3.
  • Ince, S., D. Arslan-Acaroz, H. H. Demirel, N. Varol, H. A. Ozyurek, F. Zemheri, and I. Kucukkurt. 2017. “Taurine Alleviates Malathion Induced Lipid Peroxidation, Oxidative Stress, and Proinflammatory Cytokine Gene Expressions in Rats.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 96: 263–268. doi:10.1016/j.biopha.2017.09.141.
  • İnce, S., U. Acaröz, D. A. Acaröz, N. Varol, Z. Gürler, İ. Küçükkurt, H. H. Demirel, and A. Eryavuz. 2018. “Protective Effect of Taurine Against Acrylamide-Induced Oxidative Stress in Rats.” Kocatepe Veterinary Journal 11 (4): 479–490.
  • Kerai, M. D. J., C. J. Waterfield, S. H. Kenyon, D. S. Asker, and J. A. Timbrell. 1998. “Taurine: Protective Properties Against Ethanol-Induced Hepatic Steatosis and Lipid Peroxidation during Chronic Ethanol Consumption in Rats.” Amino Acids 15 (1-2): 53–76. doi:10.1007/BF01345280.
  • Lambert, I. H., D. M. Kristensen, J. B. Holm, and O. H. Mortensen. 2015. “Physiological Role of Taurine-from Organism to Organelle.” Acta Physiologica (Oxford, England) 213 (1): 191–212. doi:10.1111/Apha.12365.
  • Lee, I. C., S. H. Kim, H. S. Baek, C. Moon, S. H. Kim, Y. B. Kim, W. K. Yun, H. C. Kim, and J. C. Kim. 2015. “Protective Effects of Diallyl Disulfide on Carbon Tetrachloride-Induced Hepatotoxicity Through Activation of Nrf2 .” Environmental Toxicology 30 (5): 538–548. doi:10.1002/tox.21930.
  • Li, J. X., Y. Z. Pang, C. S. Tang, and Z. Q. Li. 2004. “Protective Effect of Taurine on Hypochlorous Acid Toxicity to Nuclear Nucleoside Triphosphatase in Isolated Nuclei from Rat Liver.” World Journal of Gastroenterology 10 (5): 694–698. doi:10.3748/wjg.v10.i5.694.
  • Li, S., B. K. Wei, J. Wang, G. Dong, and X. Wang. 2019. “Taurine Supplementation Ameliorates Arsenic-Induced Hepatotoxicity and Oxidative Stress in Mouse”. In Taurine 11, edited by J Hu, F Piao, S Schaffer, A El Idrissi and JY Wu, 463–470. Singapore: Springer.
  • Li, S., L. Yang, G. Dong, and X. Wang. 2017. “Taurine Protects Mouse Liver Against Arsenic-Induced Apoptosis Through JNK Pathway.” Advanced Experimental Medicine Biology 975: 855–862. doi:10.1007/978-94-024-1079-2_67.
  • Loubières, Y., A. D. Lassence, M. Bernier, A. Vieillard-Baron, J. M. Schmitt, B. Page, and F. Jardin. 1999. “Acute, Fatal, Oral Chromic Acid Poisoning.” Journal of Toxicology. Clinical Toxicology 37 (3): 333–336. doi:10.1081/clt-100102431.
  • Lourenco, R., and M. E. Camilo. 2002. “Taurine: A Conditionally Essential Amino Acid in Humans? An Overview in Health and Disease.” Nutricion Hospitalaria 17 (6): 262–270.
  • Miyazaki, T., and Y. Matsuzaki. 2014. “Taurine and Liver Diseases: A Focus on the Heterogeneous Protective Properties of Taurine.” Amino Acids 46 (1): 101–110. doi:10.1007/S00726-012- 1381-0.
  • Miyazaki, T., M. Karube, Y. Matsuzaki, T. Ikegami, M. Doy, N. Tanaka, and B. Bouscarel. 2005. “Taurine Inhibits Oxidative Damage and Prevents Fibrosis in Carbon Tetrachloride-Induced Hepatic Fibrosis.” Journal of Hepatology 43 (1): 117–125. doi:10.1016/j.jhep.2005.01.033.
  • Miyazaki, T., S. I. Sasaki, A. Toyoda, M. Shirai, T. Ikegami, Y. Matsuzaki, and A. Honda. 2019. “Influences of Taurine Deficiency on Bile Acids of the Bile in the Cat Model.” Advances in Experimental Medicine and Biology 1155: 35–44. doi:10.1007/978-981-13-8023-5_4.
  • Nagai, K., S. Fukuno, A. Oda, and H. Konishi. 2016. “Protective Effects of Taurine on Doxorubicin-Induced Acute Hepatotoxicity Through Suppression of Oxidative Stress and Apoptotic Responses.” Anti-Cancer Drugs 27 (1): 17–23. doi:10.1097/CAD.0000000000000299.
  • Nakashima, T., T. Taniko, and K. Kuriyama. 1982. “Therapeutic Effect of Taurine Administration on Carbon Tetrachloride-Induced Hepatic Injury.” Japanese Journal of Pharmacology 32 (4): 583–589. doi:10.1254/jjp.32.583.
  • Niknahad, H., A. Jamshidzadeh, R. Heidari, M. Zarei, and M. M. Ommati. 2017. “Ammonia-Induced Mitochondrial Dysfunction and Energy Metabolism Disturbances in Isolated Brain and Liver Mitochondria, and the Effect of Taurine Administration: Relevance to Hepatic Encephalopathy Treatment.” Clinical and Experimental Hepatology 3 (3): 141–151. doi:10.5114/ceh.2017.68833.
  • O'Brien, P. J. 1991. “Molecular Mechanisms of Quinone Cytotoxicity.” Chemico-Biological Interactions 80 (1): 1–41. doi:10.1016/0009-2797(91)90029-7.
  • Olson, J. R., M. J. Hosko, and J. M. Fujimoto. 1979. “Alterations in the Liver Cell Transmembrane Potential Following CCL4 and Bile Salt Treatment of Rats.” Life Sciences 25 (24-25): 2043–2050. 90195-4. doi:10.1016/0024-3205(79).
  • Parvez, S., H. Tabassum, B. D. Banerjee, and S. Raisuddin. 2008. “Taurine Prevents Tamoxifen-Induced Mitochondrial Oxidative Damage in Mice .” Basic & Clinical Pharmacology & Toxicology 102 (4): 382–387. doi:10.1111/j.1742-7843.2008.00208.x.
  • Peiró, A. M., P. Zapater, C. Alenda, A. Ramírez, A. Gutiérrez, M. Pérez-Mateo, and J. Such. 2007. “Hepatotoxicity Related to Paraquat and Diquat Absorption Through Intact Skin.” Digestive Diseases and Sciences 52 (11): 3282–3284. doi:10.1007/S10620-005-9056-2.
  • Piao, F., Y. Zhang, L. Yang, C. Zhang, J. Shao, X. Liu, Y. Li, and S. Li. 2017. “Taurine Attenuates As2O3-Induced Autophagy in Cerebrum of Mouse Through Nrf2 Pathway.” Advances in Experimental Medicine and Biology 975 Pt 2: 863–870. doi:10.1007/978-94-024-1079-2_68.
  • Pushpakiran, G., K. Mahalakshmi, and C. V. Anuradha. 2004a. “Protective Effects of Taurine on Glutathione and Glutathione-Dependent Enzymes in Ethanol-Fed Rats.” Die Pharmazie-An International Journal of Pharmaceutical Sciences 59 (11): 869–872.
  • Pushpakiran, G., K. Mahalakshmi, and C. V. Anuradha. 2004b. “Taurine Restores Ethanol-Induced Depletion of Antioxidants and Attenuates Oxidative Stress in Rat Tissues.” Amino Acids 27 (1): 91–96. doi:10.1007/s00726-004-0066-8.
  • Qiu, T., P. Pei, X. Yao, L. Jiang, S. Wei, Z. Wang, J. Bai, et al. 2018. “Taurine Attenuates Arsenic-Induced Pyroptosis and Nonalcoholic Steatohepatitis by Inhibiting the Autophagic-Inflammasomal Pathway.” Cell Death & Disease 9 (10): 1–16. doi:10.1038/s41419-018-1004-0.
  • Razavi-Azarkhiavi, K., M. Iranshahy, A. Sahebkar, K. Shirani, and G. Karimi. 2016. “The Protective Role of Phenolic Compounds against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review.” Nutrition and Cancer 68 (6): 892–917. doi:10.1080/01635581.2016.1187280.
  • Razavi-Azarkhiavi, K., M. R. Jaafari, K. Abnous, B. M. Razavi, A. H. Jafarian, F. V. Hassani, K. Shirani, and G. Karimi. 2017. “The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: A Study Focused on Microrna Role for Toxicity Assessment of New Formulations.” Pharmaceutical Research 34 (9): 1849–1856. doi:10.1007/S11095-017-2194-3.
  • Rikans, L. E., and T. Yamano. 2000. “Mechanisms of Cadmium‐Mediated Acute Hepatotoxicity.” Journal of Biochemical and Molecular Toxicology 14 (2): 110–117. doi:10.1002/(sici)1099-0461(2000)14:2 < 110::aid-jbt7 > 3.0.co;2-j.
  • Roy, A., and C. S. Parames. 2012. “Taurine Protects Murine Hepatocytes Against Oxidative Stress-Induced Apoptosis by Tert-Butyl Hydroperoxide via PI3K/Akt and Mitochondrial-Dependent Pathways.” Food Chemistry 131 (4): 1086–1096. doi:10.1016/j.foodchem.2011.09.057.
  • Saleh, A. A. S., M. I. Shahin, and N. A. Kelada. 2017. “Hepatoprotective Effect of Taurine and Coenzyme Q10 and Their Combination Against Acrylamide-Induced Oxidative Stress in Rats.” Tropical Journal of Pharmaceutical Research 16 (8): 1849–1855. doi:10.4314/tjpr.v16i8.14.
  • Santos, N. A. G., W. S. G. Medina, N. M. Martins, F. E. Mingatto, C. Curti, and A. C. Santos. 2008. “Aromatic Antiepileptic Drugs and Mitochondrial Toxicity: Effects on Mitochondria Isolated from Rat Liver.” Toxicology In Vitro : An International Journal Published in Association with BIBRA 22 (5): 1143–1152. doi:0.1016/j.tiv.2008.03.004. doi:10.1016/j.tiv.2008.03.004.
  • Sarkar, M. K., and P. C. Sil. 2010. “Prevention of Tertiary Butyl Hydroperoxide Induced Oxidative Impairment and Cell Death by a Novel Antioxidant Protein Molecule Isolated from the Herb, Phyllanthus Niruri.” Toxicology in Vitro : An International Journal Published in Association with BIBRA 24 (6): 1711–1719. doi:10.1016/j.tiv.2010.05.014.
  • Schaffer, S.,. J. Azuma, K. Takahashi, and M. Mozaffari. 2003. “Why Is Taurine Cytoprotective?” Advances in Experimental Medicine and Biology 526: 307–321. doi:10.1007/978-1-4615-0077-3_39.
  • Schaffer, S. W., T. Ito, and J. Azuma. 2014. “Clinical Significance of Taurine.” Amino Acids 46 (1): 1–5. doi:10.1007/S00726-013-1632-8.
  • Shao, A., and J. N. Hathcock. 2008. “Risk Assessment for the Amino Acids Taurine, L-Glutamine and L-Arginine.” Regulatory Toxicology and Pharmacology : RTP 50 (3): 376–399. doi:10.1016/J.Yrtph.2008.01.004.
  • Shirani, K., H. B. Bostan, A. Baroti, M. Hassanzadeh, Z. Khashyarmanesh, H. M. Haghighi, and G. Karimi. 2018. “Ethanol and Methanol Concentration in Commonly Used Brands of Ma-Al-Shaeer in Iran: Estimation of Dietary Intakes and Risk Assessment.” Journal of Pharmacopuncture 21 (3): 168–176. doi:10.3831/KPI.2018.21.020.
  • Shirani, K., N. Shahbazi, M. H. Khayat, Z. Khashayarmanesh, F. V. Hassani, N. Moharerri, H. M. Haghighi, and G. Karimi. 2017. “Concentration of Heavy Metals in Iranian Market Rice and Associated Population Health Risk.” Quality Assurance and Safety of Crops & Foods 9 (3): 249–254. doi:10.3920/QAS2015.0667.
  • Sinha, M., P. Manna, and P. C. Sil. 2007. “Taurine, a Conditionally Essential Amino Acid, Ameliorates Arsenic-Induced Cytotoxicity in Murine Hepatocytes.” Toxicology in Vitro : An International Journal Published in Association with BIBRA 21 (8): 1419–1428. doi:10.1016/j.tiv.2007.05.010.
  • Sinha, M., P. Manna, and P. C. Sil. 2009. “Induction of Necrosis in Cadmium-Induced Hepatic Oxidative Stress and Its Prevention by the Prophylactic Properties of Taurine.” Journal of Trace Elements in Medicine and Biology : organ of the Society for Minerals and Trace Elements (GMS) 23 (4): 300–313. doi:10.1016/j.jtemb.2009.03.010.
  • Spechler, S. J., H. Sperber, W. G. Doos, and R. S. Koff. 1981. “Cholestasis and Toxic Epidermal Necrolysis Associated with Phenytoin Sodium Ingestion: The Role of Bile Duct Injury.” Annals of Internal Medicine 95 (4): 455–456. doi:10.7326/0003-4819-95-4-455.
  • Tabassum, H., H. Rehman, B. D. Banerjee, S. Raisuddin, and S. Parvez. 2006. “Attenuation of Tamoxifen-Induced Hepatotoxicity by Taurine in Mice.” Clinica Chimica Acta; International Journal of Clinical Chemistry 370 (1-2): 129–136. doi:10.1016/j.cca.2006.02.006.
  • Tang, R., Q. Yang, S. Lin, Y. Feng, J. Yang, Q. Lv, G. Wu, and J. Hu. 2019. “Preventive or Curative Administration of Taurine Regulates Lipid Metabolism in the Liver of Rats with Alcoholic Liver Disease.” Advances in Experimental Medicine and Biology 1155: 119–131. doi:10.1007/978-981-13-8023-5_11.
  • Taziki, S., V. Khori, M. Jahanshahi, A. Seifi, F. B. Babakordi, and E. N. Nikmahzar. 2018. “Protective Role of Taurine Against Hepatotoxicity Induced by Pyrazinamide in Rats.” National Journal of Physiology, Pharmacy and Pharmacology 8 (6): 1–828. doi:10.5455/njppp.2018.8.0101805022018.
  • Trautwein, E. A., and K. C. Hayes. 1990. “Taurine Concentrations in Plasma and Whole Blood in Humans: Estimation of Error from Intra- and Interindividual Variation and Sampling Technique.” The American Journal of Clinical Nutrition 52 (4): 758–764. doi:10.1093/ajcn/52.4.758.
  • Uzunhisarcikli, M., and A. Aslanturk. 2019. “Hepatoprotective Effects of Curcumin and Taurine Against Bisphenol A-Induced Liver Injury in Rats.” Environmental Science and Pollution Research International 26 (36): 37242–37253. doi:10.1007/S11356-019-06615-8.
  • Wands, J. R., E. A. Smuckler, and W. J. Woodbury. 1970. “Transmembrane Potential Changes in Liver Cells following CCL4 Intoxication.” The American Journal of Pathology 58 (3): 499–508.
  • Wang, Z., Y. Tao, T. Qiu, X. Yao, L. Jiang, N. Wang, S. Wei, et al. 2019. “Taurine Protected As2O3-Induced the Activation of Hepatic Stellate Cells Through Inhibiting Pparα-Autophagy Pathway.” Chemico-Biological Interactions 300: 123–130. doi:10.1016/j.cbi.2019.01.019.
  • Warskulat, U., E. Borsch, R. Reinehr, B. Heller-Stilb, I. Mönnighoff, D. Buchczyk, M. Donner, et al. 2006. “Chronic Liver Disease Is Triggered by Taurine Transporter Knockout in the Mouse.” FASEB Journal : official Publication of the Federation of American Societies for Experimental Biology 20 (3): 574–576. doi:10.1096/fj.05-5016fje.
  • Waterfield, C. J., M. Mesquita, P. Parnham, and J. A. Timbrell. 1993. “Taurine Protects Against the Cytotoxicity of Hydrazine, 1, 4-Naphthoquinone and Carbon Tetrachloride in Isolated Rat Hepatocytes.” Biochemical Pharmacology 46 (4): 589–595. doi:10.1016/0006-2952(93)90542-5.
  • Whiting, P. H., and A. W. Thompson. 1989. “Pathological Effects of Cyclosporin A in Experimental Models.” In Cyclosporin, edited by A. W. Thompson, 303–323. Lancaster, UK: Kluwer Academic publishers.
  • Wu, C., D. O. Kennedy, Y. Yano, S. Otani, and I. Matsui ‐Yuasa. 1999. “Thiols and Polyamines in the Cytoprotective Effect of Taurine on Carbon Tetrachloride‐Induced Hepatotoxicity.” Journal of Biochemical and Molecular Toxicology 13 (2): 71–76. doi:10.1002/(sici)1099-0461(1999)13:2 < 71::aid-jbt2 > 3.0.co;2-k.
  • Wu, G., J. Yang, H. Lv, W. Jing, J. Zhou, Y. Feng, S. Lin, Q. Yang, and J. Hu. 2018. “Taurine Prevents Ethanol-Induced Apoptosis Mediated by Mitochondrial or Death Receptor Pathways in Liver Cells.” Amino Acids 50 (7): 863–875. doi:10.1007/s00726-018-2561-3.
  • Wua, C., C. Miyagawa, D. O. Kennedy, Y. Yano, S. Otani, and I. Matsui-Yuasa. 1997. “Involvement of Polyamines in the Protection of Taurine Against the Cytotoxicity of Hydrazine or Carbon Tetrachloride in Isolated Rat Hepatocytes.” Chemico-Biological Interactions 103 (3): 213–224. doi:10.1016/S0009-2797(96)03760-X.
  • Zhang, Z., D. Liu, B. Yi, Z. Liao, L. Tang, Y. Dong and M. He. 2014. “Taurine Supplementation Reduces Oxidative Stress and Protects the Liver in An Iron-Overload Murine Model.” Molecular Medicine Reports 10 (5): 2255–2262. doi: 10.3892/mmr.2014.2544.
  • Zhang, C., X. Liu, S. Li, W. Guo, M. Chen, X. Yan, L. Jiang, and F. Piao. 2017. “Taurine Normalizes the Levels of Se, Cu, Fe in Mouse Liver and Kidney Exposed to Arsenic Subchronically.” In Taurine 10, edited by DH Lee, SW Schaffer, E Park, HW Kim, 843–853. Dordrecht: Springer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.